Table 2.
Number of Cardiometabolic Risk Factors | Cardiometabolic Risk Factor Cluster | ACE or ARB (%) | Any Diuretic (%) | CCB (%) | BB (%) | Total # (%) of Patients | # of antihypertensive meds (mean, SD) |
---|---|---|---|---|---|---|---|
0 | -O -DM -HL | 57.6% | 42.7% | 25.9% | 31.1% | 1197 (18.3%) | 1.7 (1.1) |
1 | -O -DM +HL | 60.3% | 42.3% | 29.1% | 36.7% | 1537 (23.5%) | 1.8 (1.0) |
+O -DM -HL | 60.5% | 50.6% | 28.5% | 31.8% | 959 (14.7%) | 1.9 (1.1) | |
-O +DM -HL | 67.1% | 45.7% | 27.2% | 38.7% | 173 (2.7%) | 2.0 (1.1) | |
2 | +O -DM +HL | 65.1% | 53.3% | 26.7% | 39.8% | 1178 (18.0%) | 2.0 (1.1) |
-O +DM +HL | 78.7% | 43.8% | 29.5% | 42.6% | 441 (6.8%) | 2.1 (1.2) | |
+O +DM -HL | 73.5% | 52.2% | 32.7% | 36.3% | 245 (3.8%) | 2.2 (1.3) | |
3 | +O +DM +HL | 82.1% | 58.2% | 32.1% | 42.0% | 797 (12.2%) | 2.4 (1.2) |
Total (n = 6,527) | 65.3% | 48.1% | 28.5% | 36.6% | 6527 (100.0%) | 2.0 (1.1) |
O = obese (BMI ≥ 30); DM = diabetes; HL = dyslipidemia.
Row percentages by medication class do not total to100% since patients may be using more than one antihypertensive medication class.